
Using two feet or two wheels to get back and forth to work each day could reduce the inflammation that leads to cancer, heart disease and diabetes, new research shows. So-called “active commuting” — walking or biking to work — for at least 45 minutes daily lowered levels of a blood marker for inflammation called C-reactive protein (CRP), Finnish researchers report. That was true even after the team factored in any other exercise the active commuters might have been doing. Avoiding cars and buses to get to work is also good for the planet, they noted. So, “in addition to climate change mitigation, active commuting could lead to public health benefits,” concluded a team led by Sara Allaouat, a researcher at the University of Eastern Finland in Kuopio. It’s normal for people to suffer brief periods of inflammation, which is part of the body’s healthy short-term immune response. However, chronic inflammation lasts for months or years, and prior research has shown that it can raise the risk for a host of common health problems. Exercise has long been known to reduce inflammation. In the new study, Allaouat and her colleagues examined the commuting habits and blood CRP levels of over 6,200 middle-aged Finnish workers. Compared to folks who drove or took transit to work, those who spent at least 45 minutes per days walking or cycling… read on > read on >